In Segment C, members will acquire ABBV-744 and oral navitoclax. In Phase D, members will get ABBV-744 and ruxolitinib. Individuals will obtain treatment until finally disease progression or even the members are not able to tolerate the study drugs. and then endorse H3K27Ac at this location. Chromatin hyperacetylation could enhance https://samirf433rcn6.boyblogguide.com/profile